SCHEMBL10499684

SCHEMBL10499684

C=CC(=O)Oc1c(C)cccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ THRB P10828 3/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ GSR P00390 1/20 0.36
▸ THRA P10827 1/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ FABP3 P05413 1/20 0.35
▸ FABP4 P15090 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25565205 0.88 L3MBTL1 (0.47) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL6658293 0.81 KMT2A (0.40) ALDH1A1HPGDKMT2ATHRBGSR
SCHEMBL29657033 0.81 THRB (0.42) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL28910060 0.80 HPGD (0.40) KDM4EALDH1A1HPGDKMT2ATHRB
SCHEMBL28624346 0.80 KMT2A (0.39) ALDH1A1HPGDKMT2AL3MBTL1THRB
SCHEMBL28134133 0.80 HSD17B10 (0.39) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL28954462 0.80 ALDH1A1 (0.39) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL28133169 0.80 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL20534013 0.80 KMT2A (0.39) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL27730838 0.80 BCL2A1 (0.38) ALDH1A1HPGDKMT2ATHRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116234798-A Sulfamate derivative compounds for the treatment or alleviation of psychotic disorders 生物药品解决方案有限公司 2023-06-06 — — CN disclosed
CN-106507667-B Sulfamate derivatives for the prevention or treatment of epilepsy 比皮艾思药物研发有限公司 2020-01-24 — — CN disclosed
CN-106456599-B For treating or mitigating the sulphamate derivs compound of pain 比皮艾思药物研发有限公司 2019-05-14 — — CN disclosed
CN-106456599-A Sulfamate derivative compounds for use in treating or alleviating pain 比皮艾思药物研发有限公司 2017-02-22 — — CN disclosed
US-4835312-A Production process of N-substituted amide compounds MITSUI CHEMICALS, INCORPORATED (JP) 1989-05-30 — — US disclosed
Send feedback